Literature DB >> 10640900

Giant prolactinoma presented as unilateral exophthalmos in a prepubertal boy: response to cabergoline.

G E Krassas1, N Pontikides, T Kaltsas.   

Abstract

We report the case of a giant prolactinoma in a 7-year-old boy, which was complicated by unilateral exophthalmos. The initial levels of prolactin (PRL) were about 80,000 microU/ml. Treatment with cabergoline (CAB) resulted in rapid normalization of serum PRL (6 weeks after initiation of treatment) and reduction of tumor size. In particular, magnetic resonance imaging (MRI), which was done 2.5 months after the patient was put on CAB, revealed tremendous improvement with a decrease in the size of the tumor which now showed no extrasellar extension. Subsequent MRI studies demonstrated further improvement. Exophthalmos, anisocoria and visual fields improved. In summary, this patient represents the first report of the therapeutic use of CAB as the primary mode of treatment in a 7-year-old boy with infiltrative giant prolactinoma complicated by unilateral exophthalmos. It is a noninvasive treatment that can preserve and restore vision, as well as pituitary function, and is preferable to surgery or radiation in the treatment of prolactin-secreting macroadenoma in childhood and adolescence. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10640900     DOI: 10.1159/000023432

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  5 in total

1.  [Temporary, undefined, unilateral eyeball movement disorder].

Authors:  P S Mauz; U Ernemann; M M Maassen; A Baisch; S Brosch
Journal:  HNO       Date:  2004-11       Impact factor: 1.284

2.  Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.

Authors:  Arijit Chattopadhyay; Anil Bhansali; Shariq R Masoodi
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Multidisciplinary treatment of giant invasive prolactinomas in paediatric age: long-term follow-up in two children.

Authors:  Mario Francesco Fraioli; Federica Novegno; Elisabetta Catena; Chiara Fraioli; Laura Moschettoni
Journal:  Childs Nerv Syst       Date:  2010-03-30       Impact factor: 1.475

4.  Giant prolactinomas in adolescence: an uncommon cause of blindness.

Authors:  Patrick Semple; Graham Fieggen; Jeannette Parkes; Naomi Levitt
Journal:  Childs Nerv Syst       Date:  2006-09-16       Impact factor: 1.475

5.  Cabergoline as a first-line treatment in newly diagnosed macroprolactinomas.

Authors:  N Pontikides; G E Krassas; E Nikopoulou; T Kaltsas
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.